VTP-43742
-
Ft. Washington’s Vitae Pharma Closes Stock Sale
Vitae Pharmaceuticals Inc., a Fort Washington biotechnology company, closed its public stock offering. It generated $35 million in proceeds, writes John…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
